1. A6 TREATMENT TRIAL RESULTS FROM COMMUNITY H. PYLORI PROJECTS IN ARCTIC CANADA. (15th March 2019) Authors: Veldhuyzen van Zanten, S; Morse, A; Morse, J; Girgis, S; Assi, A; Fagan-Garcia, K; Geary, J; Goodman, K Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alveolar Soft-Part Sarcoma Presenting with Eosinophilia and Shunt. Issue 7 (3rd October 2005) Authors: Almansori, M; Turner, AR; Girgis, S; Vethanayagam, D Journal: Canadian respiratory journal Issue: Volume 12:Issue 7(2005) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (5th April 2022) Authors: Popat, R; Usmani, S; Garfall, A; van de Donk, N; Nahi, H; San-Miguel, J; Oriol, A; Nooka, A; Martin, T; Rosinol, L; Chari, A; Karlin, L; Benboubker, L; Mateos, M; Bahlis, N; Moreau, P; Besemer, B; Martínez-López, J; Sidana, S; Pei, L Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL-1. (5th April 2022) Authors: van de Donk, N. W. C. J; Minnema, M C; Berdeja, J G; Oriol, A; Krishnan, A; Rodríguez-Otero, P; Askari, E; Mateos, M; Costa, L. J; Verona, R; Ma, J; Girgis, S; Yang, S; Hilder, B. W; Russell, J; Goldberg, J. D; Chari, A Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. Issue 12 (17th October 2006) Authors: Palmieri, C; MacGregor, T; Girgis, S; Vigushin, D Journal: Journal of clinical pathology Issue: Volume 59:Issue 12(2006) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗